Goldman Landow Capital, LLC, offers securities through Fox Chase Capital Partners, LLC, an SEC‐­registered broker dealer, member of FINRA, SIPC, and MSRB.

© 2020 by Goldman Landow Capital, LLC


By: Mike Krasner

The Semper U.S. Treasury Money Market Fund, an innovative Government Institutional money-market mutual fund with a difference, has burst upon the scene and quickly demonstrated the ability to plump up investment returns for its investors.

The Semper U.S. Treasury Money Market Fund (Ticker: SEMXX) was launched April 16, 2018, and has since consistently outperformed all other Treasury money-market funds and, in many instances, most if not all other Government MMFs.

. . .

By: Lewis Goldman

Date: March 2018

Can a stable $1.00 NAV U.S. Treasury Money Market Fund yield the same as a floating NAV Prime Money Market Fund?


Goldman Landow Capital explores the advantages a U.S. Treasury Money Market Fund has over Prime Money Market Funds and if these advantages can lead to better performance which can narrow the gap between Treasury Funds and Prime Funds.

. . .

By: Andrew Neil, Global Investor ISF Magazine

Date: February 2017

Alpha PLUS technique revolves around back-to-back repo agreements.

. . .

Greenberg Traurig White Paper

By: Robert Frenchman

Date: January 2017

The Alpha PLUS Yield Enhancement Process – Legal Issues for Beneficial Owners.


This GT White Paper discusses legal and regulatory issues relevant to beneficial owners of U.S. Treasury securities who are interested in pursuing yield enhancement strategies. It provides some legal and regulatory context for beneficial owners to understand Alpha PLUS, a yield enhancement process that uses master repurchase agreements to effect substitutions of collateral—in this case, U.S. Treasury securities that mature within a 16-day radius—that the beneficial owner has deemed to be of equivalent yield. Each collateral substitution earns the beneficial owner a fee from a designated counterparty, as provided in an annex to the repo agreement. As discussed below, we have concluded that collateral substitutions under Alpha PLUS are not purchases or sales, are not hypothecations or rehypothecations, do not violate SEC Rule 2a-7, and do not require indemnification from a custodian or an agent lender.

. . .

To review the complete Greenberg Traurig White Paper, please submit a request to Lew Goldman at